Early developmental alterations of CA1 pyramidal cells in Dravet syndrome

Steffan P. Jones, Nathanael O’Neill, Jenna C. Carpenter, Sharon Muggeo, Gaia Colasante, Dimitri M. Kullmann, Gabriele Lignani

Neurobiology of Disease · 2024 · 10 citations · 60 references

DOIFull text

Open access

Concepts

Abstract

Dravet Syndrome (DS) is most often caused by heterozygous loss-of-function mutations in the voltage-gated sodium channel gene SCN1A (Na v 1.1), resulting in severe epilepsy and neurodevelopmental impairment thought to be cause by reduced interneuron excitability. However, recent studies in mouse models suggest that interneuron dysfunction alone does not completely explain all the cellular and network impairments seen in DS. Here, we investigated the development of the intrinsic, synaptic, and network properties of CA1 pyramidal cells in a DS model prior to the appearance of overt seizures. We report that CA1 pyramidal cell development is altered by heterozygous reduction of Scn1a , and propose that this is explained by a period of reduced intrinsic excitability in early postnatal life, during which Scn1a is normally expressed in hippocampal pyramidal cells. We also use a novel ex vivo model of homeostatic plasticity to show an instability in homeostatic response during DS epileptogenesis. This study provides evidence for the early effects of Scn1a haploinsufficiency in pyramidal cells in contributing to the pathophysiology of DS. • Scn1a is expressed in CA1 pyramidal cells at early developmental stages. • Scn1a haploinsufficiency results in CA1 pyramidal cell hypoexcitability at P10–12. • Homeostatic plasticity is altered in CA1 pyramidal cells in the pre-epileptic period.

References

60